Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

648
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
648
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

438
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
438
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

346
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
346
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

413
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Bridging Theory and Practice: Patho-Play as an Innovative Serious Game for Pathology Training in Medical Education.

La Tunisie medicale·2026
Same author

Acetylation Variability in Elderly Tunisians: Implications for Isoniazid Dose Individualization.

Journal of clinical pharmacology·2026
Same author

Clinicopathological significance of microRNA-9 and microRNA-34 methylation in non-small cell lung cancer.

Biochemistry and biophysics reports·2026
Same author

Atypical Presentation of Grade III Hand-Foot Syndrome in a Patient With Breast Cancer Receiving Docetaxel.

American journal of therapeutics·2026
Same author

A comparative study of medical student performance and satisfaction in an in-person vs online chronic pain certificate program.

La Tunisie medicale·2026
Same author

Therapeutic Clozapine Monitoring Using Dose-Related Reference Range.

Therapeutic drug monitoring·2026
Same journal

Abstracts International Scientific Day on Oxidative Stress, Aging, and Age-Related Diseases.

La Tunisie medicale·2026
Same journal

Pharmacological evaluation of anti-inflammatory potential and antispasmodic effect of aqueous extract from the brown seaweed, Cystoseira compressa.

La Tunisie medicale·2026
Same journal

Assessing the Accuracy of LDL-Cholesterol Estimation Formulas in the Tunisian Population.

La Tunisie medicale·2026
Same journal

Assessment of liver fibrosis in Chronic hepatitis B: performance of hematological parameters.

La Tunisie medicale·2026
Same journal

Association between Oxidative Stress, Cardiovascular Risk, and Disease Activity in Patients with Spondyloarthritis: A Cross-Sectional Study in a Tunisian Cohort.

La Tunisie medicale·2026
Same journal

Assessment of oral cancer awareness among dentists in Tunisia: A cross-sectional study.

La Tunisie medicale·2026
関連記事をすべて見る

関連する実験動画

Updated: May 5, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

7.2K

Syrine Moussa1, Rim Charfi1, Khouloud Ferchichi1

  • 1University of Tunis El Manar, Faculty of Medicine of Tunis, 1007, Centre National Chalbi Belkahia de Pharmacovigilance, Service de Pharmacologie Clinique, LR16SP02, 1006, Tunis, Tunisia.

La Tunisie medicale
|February 19, 2026
PubMed
まとめ
この要約は機械生成です。

薬剤耐性は,ラモトリジン (LMT) を服用している小児性患者の38.6%に影響します. 耐性症例では,より高いLMTの最低値が観察され,TDMは子供におけるの管理に不可欠であることを示唆しています.

キーワード:
子供 子供 子供 子供 子供 子供薬剤耐性 薬剤耐性 薬剤耐性 薬剤耐性汎用性エピレプシー 汎用性エピレプシーとはラモトリジン (Lamotrigine) とは,ラモトリジン (Lamotrigine) とは,ラモトリジン (Lamotrigine) とは治療薬のモニタリング

さらに関連する動画

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

22.8K
A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
08:23

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy

Published on: November 13, 2016

10.1K

関連する実験動画

Last Updated: May 5, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

7.2K
Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

22.8K
A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
08:23

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy

Published on: November 13, 2016

10.1K

科学分野:

  • 小児神経学について
  • 臨床薬理学 臨床薬理学とは
  • エピレプシの研究研究

背景:

  • エピレプシは一般的な,障害を与える神経学的疾患で,しばしば幼児期に発症します.
  • 薬剤耐性性 (DRE) は,生活の質と社会・職業的統合を著しく損なう.
  • ラモトリジン (LMT) の治療薬モニタリング (TDM) は,困難な小児症例の管理を助けます.

研究 の 目的:

  • LMT.で薬剤耐性性 (DRE) を有する子どもを特定する.
  • 子供におけるLMT耐性に関連した人口統計的,臨床的,および薬理学的要因を評価する.
  • 小児性におけるLMT治療の最適化のためのTDMの有用性を評価する.

主な方法:

  • リトロスペクティブ・ディスクリプティブ・スタディ (2012~2021年).
  • LMT.を服用している114人の小児性患者 (18歳未満) を含む.
  • TDMの最低血濃度 (C0) を分析した.

主要な成果:

  • 子供の38.6%がLMTに対する薬剤耐性を示した.
  • 薬剤耐性は,男の子 (73%) でより一般的でした.
  • 薬剤耐性患者では,LMT C0 (8.7 μg/mL vs. 4.75 μg/mL) が著しく高かった.
  • 低生物利用性は,耐性症例の20.5%で報告されました.

結論:

  • LMTに対する薬剤耐性は,小児性患者の3分の1以上に影響します.
  • 高い残留LMT濃度は薬剤耐性に関連しています.
  • LMTのTDMは,小児性における抵抗性の特定と管理に価値があります.